AstraZeneca Market Cap 2006-2019 | AZN

AstraZeneca market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AstraZeneca market cap as of January 21, 2020 is $133.29B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $133.287B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.860B 17.02
Roche Holding AG (RHHBY) Switzerland $290.718B 0.00
Merck (MRK) United States $229.062B 17.75
Pfizer (PFE) United States $223.247B 13.27
Novartis AG (NVS) Switzerland $218.156B 18.41
Novo Nordisk (NVO) Denmark $144.780B 24.95
Eli Lilly (LLY) United States $135.292B 24.98
AbbVie (ABBV) United States $130.121B 10.20
Sanofi (SNY) France $125.733B 15.45
GlaxoSmithKline (GSK) United Kingdom $118.475B 14.35
Bristol-Myers Squibb (BMY) United States $109.863B 15.36
Bayer (BAYRY) Germany $78.278B 11.59
H Lundbeck (HLUYY) Denmark $8.258B 14.35